Patents expiring in 2036

US 9463220

Method for inducing twin calving

China Agricultural University · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463233

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463216

Poly-glutamic acid anti-anthrax compositions and methods for using the same

The Regents of the University of California · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463234

Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463254

Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

The Board of Regents of the University of Texas System · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463247

Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents

Alnylam Pharmaceuticals, Inc. · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464102

Prodrugs of pyridone amides useful as modulators of sodium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464130

Nucleic acids encoding a cold- and menthol-sensitive receptor

The Regents of the University of California · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464125

Engineered potent cytotoxic stapled BH3 peptides

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464135

Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464060

Compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464132

Nanoantibodies, binding Chlamydia trachomatis antigen, method for inhibition of infection induced by Chlamydia trachomatis

OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP” · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9464035

Salicylic acid derivatives useful as glucocerebrosidase activators

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463195

Dissolution of amyloid fibrils by flavonoids and other compounds

The Regents of the University of California · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9463179

Short acting phenylalkylamine calcium channel blockers and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9462794

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

PT 2481410

NITROCATECHOL DERIVATES AS COMT INHIBITORS ADMINISTERED WITH A SPECIFIC DOSAGE REGIME

BIAL-PORTELA & Cª S A [PT] · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9469683

Lysosomal targeting peptides and uses thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9469878

Methods of treating cancer comprising targeting NQO1

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9469879

Lymphoma prognostic methods and kits

Regents of the University of Minnesota · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9470689

N-cadherin: target for cancer diagnosis and therapy

The Regents of the University of California · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468649

Methods of treating epilepsy with transforming growth factor beta inhibitors

The Regents of the University of California · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468208

Disease control with tick phospholipase A2

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468611

d-Methadone for the treatment of psychiatric symptoms

Relmada Therapeutics, Inc. · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468669

Methods to treat dysregulated blood glucose disorders

Regents of the University of Minnesota · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468684

Hydrogel implants with varying degrees of crosslinking

Covidien LP · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468624

Small molecule antagonists of bacterial quorum-sensing receptors

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9469637

Nitrogenated heterocyclic compound

Takeda Pharmaceutical Company Limited · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9469664

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

Sarepta Therapeutics, Inc. · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9468632

Methods and compositions for targeting cancer stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9475869

Human antibodies to fel d1 and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474730

Methods and compositions for use with K-ras mediated disorders

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474716

SiRNA phospholipid conjugate

Northwestern University · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9475832

Phosphonates with reduced toxicity for treatment of viral infections

The Regents of the University of California · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9475795

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

Takeda Pharmaceutical Company Limited · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474795

Polysaccharide-protein conjugate vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474793

Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474743

Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

PTC THERAPEUTICS, INC. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474779

Therapeutically active compositions and their methods of use

Agios Pharmaceuticals, Inc. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474784

Therapeutic applications of SMAD7

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474796

Crimean-Congo hemorrhagic fever virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474787

Mesenchymal stem cells for the treatment of CNS diseases

BRAINSTORM CELL THERAPEUTICS LTD. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474797

African swine fever virus georgia strain adapted to efficiently grow in the vero cell line

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474804

Poly(vinyl ester) polymers for in vivo nucleic acid delivery

Arrowhead Pharmaceuticals, Inc. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474830

PEGylated fibrinogen precursor molecule

REGENTIS BIOMATERIALS LTD. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9474768

Lubricant formulations

Reoxcyn Discoveries Group, Inc. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9475781

Fumarate analogs and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9475816

Substituted-1,4-dihydropyrazolo[4,3-b]indoles

Takeda Pharmaceutical Company Limited · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)